Literature DB >> 23355733

Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.

Ravi P Sahu1, Irina Petrache, Mary J Van Demark, Badri M Rashid, Jesus A Ocana, Yuxuan Tang, Qiaofang Yi, Matthew J Turner, Raymond L Konger, Jeffrey B Travers.   

Abstract

Previous studies have established that pro-oxidative stressors suppress host immunity because of their ability to generate oxidized lipids with platelet-activating factor receptor (PAF-R) agonist activity. Although exposure to the pro-oxidative stressor cigarette smoke (CS) is known to exert immunomodulatory effects, little is known regarding the role of PAF in these events. The current studies sought to determine the role of PAF-R signaling in CS-mediated immunomodulatory effects. We demonstrate that CS exposure induces the generation of a transient PAF-R agonistic activity in the blood of mice. CS exposure inhibits contact hypersensitivity in a PAF-R-dependent manner as PAF-R-deficient mice were resistant to these effects. Blocking PAF-R agonist production either by systemic antioxidants or treatment with serum PAF-acetyl hydrolase enzyme blocked both the CS-mediated generation of PAF-R agonists and PAF-R-dependent inhibition of contact hypersensitivity (CHS) reactions, indicating a role for oxidized glycerophosphocholines with PAF-R agonistic activity in this process. In addition, cyclooxygenase-2 inhibition did not block PAF-R agonist production but prevented CS-induced inhibition of CHS. This suggests that cyclooxygenase-2 acts downstream of the PAF-R in mediating CS-induced systemic immunosuppression. Moreover, CS exposure induced a significant increase in the expression of the regulatory T cell reporter gene in Foxp3(EGFP) mice but not in Foxp3(EGFP) mice on a PAF-R-deficient background. Finally, regulatory T cell depletion via anti-CD25 Abs blocked CS-mediated inhibition of CHS, indicating the potential involvement of regulatory T cells in CS-mediated systemic immunosuppression. These studies provide the first evidence, to our knowledge, that the pro-oxidative stressor CS can modulate cutaneous immunity via the generation of PAF-R agonists produced through lipid oxidation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355733      PMCID: PMC3577966          DOI: 10.4049/jimmunol.1202699

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress?

Authors:  Raymond C S Seet; Chung-Yung J Lee; Wai Mun Loke; Shan Hong Huang; Huiwen Huang; Woan Foon Looi; Eng Soh Chew; Amy M L Quek; Erle C H Lim; Barry Halliwell
Journal:  Free Radic Biol Med       Date:  2011-03-17       Impact factor: 7.376

2.  Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores.

Authors:  R Kalra; S P Singh; S M Savage; G L Finch; M L Sopori
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

3.  Letter: Cellular immune responsiveness in cigarette smokers.

Authors:  N Suciu-Foca; A Molinaro; J Buda; K Reemtsma
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

4.  Immunological deficiency associated with cigarette smoke inhalation by mice. Primary and secondary hemagglutinin response.

Authors:  H J Esber; F F Menninger; A E Bogden; M M Mason
Journal:  Arch Environ Health       Date:  1973-08

Review 5.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

6.  Immunological studies on cigarette smokers. Part II: cell mediated immunity in cigarette smokers and the influence of the water-soluble fraction of cigarette smoke (WSF) on the immunity of mice.

Authors:  K Onari; K Sadamoto; M Takaishi; T Inamizu; T Ikuta; N Yorioka; S Ishioka; M Yamakido; Y Nishimoto
Journal:  Hiroshima J Med Sci       Date:  1980-06

Review 7.  PAF acetylhydrolase gene polymorphisms and asthma severity.

Authors:  D M Stafforini
Journal:  Pharmacogenomics       Date:  2001-08       Impact factor: 2.533

8.  Free-radical chemistry of cigarette smoke and its toxicological implications.

Authors:  D F Church; W A Pryor
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

9.  Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression.

Authors:  Jeffrey P Walterscheid; Stephen E Ullrich; Dat X Nghiem
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

10.  CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses.

Authors:  Susmit Suvas; Uday Kumaraguru; Christopher D Pack; Sujin Lee; Barry T Rouse
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  26 in total

1.  Enhanced Platelet-Activating Factor Synthesis Facilitates Acute and Delayed Effects of Ethanol-Intoxicated Thermal Burn Injury.

Authors:  Kathleen A Harrison; Eric Romer; Jonathan Weyerbacher; Jesus A Ocana; Ravi P Sahu; Robert C Murphy; Lisa E Kelly; Townsend A Smith; Christine M Rapp; Christina Borchers; David R Cool; Gengxin Li; Richard Simman; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

2.  Platelet-Activating Factor-Receptor and Tumor Immunity.

Authors:  Ravi P Sahu; Raymond L Konger; Jeffrey B Travers
Journal:  JSM Cell Dev Biol       Date:  2014-06-19

3.  Acute Ethanol Exposure Augments Low-Dose UVB-Mediated Systemic Immunosuppression via Enhanced Production of Platelet-Activating Factor Receptor Agonists.

Authors:  Jeffrey B Travers; Jonathan Weyerbacher; Jesus A Ocana; Christina Borchers; Christine M Rapp; Ravi P Sahu
Journal:  J Invest Dermatol       Date:  2019-01-23       Impact factor: 8.551

4.  Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Authors:  Jesus A Ocana; Eric Romer; Ravi Sahu; Sven-Christian Pawelzik; Garret A FitzGerald; Mark H Kaplan; Jeffrey B Travers
Journal:  J Immunol       Date:  2018-04-25       Impact factor: 5.422

5.  Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Authors:  Ravi P Sahu; Jesus A Ocana; Kathleen A Harrison; Matheus Ferracini; Christopher E Touloukian; Mohammed Al-Hassani; Louis Sun; Mathew Loesch; Robert C Murphy; Sandra K Althouse; Susan M Perkins; Paul J Speicher; Douglas S Tyler; Raymond L Konger; Jeffrey B Travers
Journal:  Cancer Res       Date:  2014-10-10       Impact factor: 12.701

6.  Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.

Authors:  Ravi Prakash Sahu
Journal:  Mol Med Rep       Date:  2015-02-18       Impact factor: 2.952

Review 7.  Daily Lifestyle and Inflammatory Skin Diseases.

Authors:  Yu Sawada; Natsuko Saito-Sasaki; Emi Mashima; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

8.  Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release.

Authors:  Christina Borchers; Anita Thyagarajan; Christine M Rapp; Jeffrey B Travers; Ravi P Sahu
Journal:  Med Sci (Basel)       Date:  2021-05-18

9.  Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor.

Authors:  Matheus Ferracini; Francisco J O Rios; Mateus Pecenin; Sonia Jancar
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

10.  Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.

Authors:  Patrick C Hackler; Sarah Reuss; Raymond L Konger; Jeffrey B Travers; Ravi P Sahu
Journal:  Cancer Growth Metastasis       Date:  2014-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.